Articles
Top ten innovators in pharma: Dennis Urbaniak

Top ten innovators in pharma: Dennis Urbaniak

We interview Dennis Urbaniak, nominated as top pharma innovator for being the mind and the force behind Sanofi’s innovative approach to engaging in social media. We asked you to nominate those who you considered to be a top innovator in pharma. We were delighted with your responses and....

Articles
Rare disease insight: interview with Timothy Coté

Rare disease insight: interview with Timothy Coté

As our rare disease focus month continues, we interview Dr Timothy Coté, former Director of FDA’s Office of Orphan Products Development, on the Orphan Drug Act and the impact it has had on this previously neglected area. There are approximately 7,000 rare diseases, 200 of which have become treatable attributed, in no small part to the Orphan Drug…

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. ESMO26: Tango sees 82% ORR with combo in pancreatic cancer
  2. Roche offers $15bn for strategic-level deal with Hansoh
  3. ESMO26: Moderna, MSD reveal cancer jab data early after leak
  4. Clinical trial setup times fall sharply in UK
  5. Despite US policy changes, drug prices stay stubbornly high

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more